Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.760
+0.060 (2.22%)
Aug 14, 2025, 1:57 PM - Market open
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $53.78 million as of August 14, 2025. Its market cap has decreased by -54.50% in one year.
Market Cap
53.78M
Enterprise Value
35.48M
1-Year Change
-54.50%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $53.78M, a decrease of -13.96%. That is a compound annual growth rate of -2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 52.61M | -24.19% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |